期刊文献+

应用PC12细胞模型研究环氧化酶-2在帕金森病发病机制中的作用

The role of Cyclooxygenase-2 in the pathogenesis of Parkinson's disease in the study with PC12 celluar model
下载PDF
导出
摘要 目的探讨环氧化酶-2(COX-2)在帕金森病(PD)发病机制中的作用。方法利用腺病毒载体将COX-2导入PC12细胞使其高表达COX-2,为实验验组;未导入COX-2的PC12细胞为对照组。两组细胞经神经生长因子(NGF)诱导后成为多巴胺能神经元,然后加入6-羟多巴(6-OHDA)诱导建立帕金森病细胞模型。分别用LDH方法和流式细胞术(FCM)检测两组细胞的损伤程度以确定COX-2是否可以作为独立因素影响PD的发病机制。结果LDH和FCM结果均显示实验组细胞损伤程度明显高于对照组(P<0.01)。结论COX-2可以提高神经元对于6-OHDA毒性的敏感性。 Objective To discuss the role of cyclooxygenase-2 (COX-2) in the pathogenesis of Parkinson' s disease (PD). Methods Experimental group consisted of PC12 cells which highly express COX-2 transfected by adenovirus vector. Control group included only PC12 cells. Both groups were induced by nerve growth factor(NGF) to differentiate into doperminergic neurons. Then adding 6-hydroxydopamine (6-OHDA) into the culture, cellular model of PD was established. Lactate dehydrogenase(LDH) and flow cytometry( FCM ) detection were administered to estimate the extent of cellular injury in order to find out whether COX-2 could influence the pathogenesis of PD as an independent factor. Result Both LDH and FCM detections showed the extent of celluar injury in the experimental group was much higher than that in control group (P 〈 0.01 ). Conclusion COX-2 could elevate the sensitivity of neurons to the toxcity induced by 6-OHDA.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2008年第5期549-553,共5页 Journal of Apoplexy and Nervous Diseases
基金 黑龙江省科技厅归国留学基金(LC06C28) 哈尔滨医科大学附属二院博士科研基金项目(BS2007-09)
关键词 环氧化酶-2 帕金森病 6-羟多巴 PC12细胞 Cyclooxygenase-2 Parkinson' s disease 6-hydroxydopamine PC12 cells
  • 相关文献

参考文献9

  • 1Nakayama M,Uchimura K,Zhu RL. Cyclooxygenase 2 inhibition prevents delayed death of CAI hippocampal neurons following global ischemia[ J]. Proc Natl Acad Sci USA, 1998,95 : 10954-10959.
  • 2Smith WL,Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases) -1 and-2 [ J ]. J Biol Chem, 1996,271 : 33157-160.
  • 3Smith CJ,Zhang Y, Koboldt CM, el al. Pharmacological analysis of cyclooxygenase-1 in inflammation [ J ]. Proc Natl Acad Sci USA, 1998,95:13313-13318.
  • 4孙圣刚,黎钢,曹学兵,童萼塘.帕金森病与炎症反应关系研究进展[J].中华神经科杂志,2003,36(6):401-403. 被引量:25
  • 5Atsmon J, Freeman ML, Meredith M J, et al. Conjugation of 9-deoxydelta 9, delta 12 (E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion[ J]. Cancer Res, 1990,50 : 1879-1885.
  • 6Kondo M,Oya Ito T,Kumagai T. Cyclopentenone prostaglandin as potential inducers of intracelluXar oxidative stress [ J ]. J Biol Chem, 2001,276 : 12076-12083.
  • 7Hinz B, Brune K, Pahl A. Cyclooxygenase-2 expression in lipopoly saccharide stimulated human monocytes is modulated by cyclic AMP, prostaglandin E2,and nonsteroidal anti inflammatory drugs[J]. Biochem Biophys Res Commun ,2002,278:790-796.
  • 8Halliwell B,Aruoma OI. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems[J]. FEBS Lett, 1991,281:9-19.
  • 9Kuhn DM,Arthur RE Jr,Thomas DM. Tyrosine hydroxylase is inactivated by catechol quinones and converted to a redox-cycling quinoprorein:possible relevance to Parkinson' s disease [ J ]. J Neurochem, 1999,73:1309-1317.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部